CompanyELUTNasdaqSilver Spring, MD

Elutia Inc.

Elutia develops drug-eluting biomatrix products for implantable medical devices designed to improve biocompatibility.

SEC EDGAR ClinicalTrials.gov elutia.com

8-KAug 21Latest SEC filing, period to Aug 17

Aug 21Latest story

August 2026

Elutia closes SimpliDerm sale to Cellution Biologics, redirects focus to NXT-41x

Aug 21M&AElutia Inc.

Elutia lines up new financing for NXT-41x, backs FDA timelines

Aug 13Quarterly updateElutia Inc.

July 2026

Elutia to sell SimpliDerm business to Cellution Biologics for up to $11 million

Jul 20PartnershipElutia Inc.